GENX Generix Group SA

Generix Group - Second Quarter Revenue 2020 / 2021

Generix Group - Second Quarter Revenue 2020 / 2021

FINANCIAL PRESS RELEASE

Paris, 26 october, 2020



Revenue for Q2 2020/2021: €19.2 M (-3 %)

Generix Group, Industrial, Logistics and Retail Ecosystems provider with leading Collaborative SaaS Solutions, issued today its revenues for the second quarter of its 2020/2021 fiscal year.

Resilient business model limits crisis impact

Q2 Revenue 2020/2021: €19.2 million (-3%)

 Quarter ended

September 30
Change6 months ended September 30Change
Unaudited (K€)2020201920202019
SaaS7 7808 076-4%15 69616 253-3%
Maintenance4 5104 888-8%8 9779 667-7%
Licenses1 3391 02930%1 8611 7298%
Software revenues13 62913 993-3%26 53427 649-4%
Consulting Services5 5585 816-4%11 56612 211-5%
Revenues19 18719 809-3%38 10039 860-4%



*Reclassification of €242 K for the second quarter and €482 K for the first half-year as Consulting and Services revenue, concerning services previously accounted for as Maintenance revenue. After reprocessing this reclassification, Maintenance revenue showed a slight drop (-3% for Q2 and -2% for H1), primarily as a result of the temporary suspension of contracts during the lockdown period. Consulting and Services revenue, which is by nature more vulnerable in the current context, dropped 9% over Q2 and H1.

The second quarter unfolded in a continuously demanding economic and health climate. However, our customers’ confidence in our ability to support them over the long term has allowed the Group to record turnover of €19.2 M, with a decrease limited to 3%. 

SaaS activities, which were slightly down, showed a drop in customary over-consumption. Contractual commitments have remained at their normal level.

License sales have grown by 30%. They were driven by a dynamic North American market, where licenses are the norm, with a threefold increase in signatures as compared to the same quarter of the previous fiscal year.

New SaaS contracts for Q2: €0.6 M

 Quarter ended September 30Var. Q2 2020 vs Q2 20196 months ended September 30Var. 2020 vs 2019
Unaudited (K€)2020201920202019
New SaaS contract signing (ACV*)648677-4%1 1811 359-13%

*New contracts signed expressed in ACV (Annual Contract Value), emphasize the average annual complementary revenue to be generated after implementing the contracts in question.

Our existing and prospective clients continued to sign new SaaS contracts amounting to €0.6 M, close to the amount recorded in the same quarter of the previous fiscal year.

Prospects

The level of revenue and signatures for the quarter is in line with Group expectations in the context of the pandemic. The hypothesis of a gradual return to normal economic activity starting from September 2020 has not yet materialized and leads the Group to anticipate a slight drop in revenue for the 2020/2021 fiscal year.

Work on cost structure suggests a controlled decrease in EBITDA margin, without including the impact of funding for Research and Development. This effort is part of the perspective to support expected growth in subsequent fiscal years.

With a healthy financial situation and better cash flow than this time last year, the Group confirms its strategy of consolidating activity in Europe and developing activity in North America.

Supplemental and non-IFRS Financial Information

Supplemental non-IFRS information (above-mentioned as EBITDA) presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered as a substitute for IFRS measurements. Also, the Company’s supplemental non-IFRS financial information may not be comparable to similarly titled non-IFRS measures used by other companies.

Next financial press release: December 7th, 2020 after the market closes

Results of the first half of the fiscal year 2020/2021

About Generix Group

Generix Group is a Collaborative Supply Chain expert present in 60 countries, thanks to its subsidiaries and network of partners. More than 6,000 companies around the world use its SaaS solutions. The group’s 650 employees provide daily support for such customers as Carrefour, Danone, FM Logistic, Fnac-Darty, Essilor, Ferrero and Geodis in the digital transformation of their Supply Chain.

Its collaborative platform, Generix Supply Chain Hub, helps companies to keep the promises they make to their customers. It combines the capabilities to execute physical flows, digitalize information flows, manage collaborative processes and connect companies to all their partners, in real time.

Generix Supply Chain Hub is aimed at all players in the Supply Chain: manufacturers, third- and fourth-party logistics providers (3PL/4PL) and retailers.

Founded in France in 1990, the company is listed on the Eurolist market of Euronext Paris, compartment C (ISIN: FR0010501692). To learn more:

 

Financial Communication Contacts:

Generix Group—Ludovic Luzza—Chief Financial Officer—Tel.: +33 (0)1 77 45 42 80 –

CIC Market Solutions—Stéphanie Stahr—Tel.: +33 (0)1 53 48 80 57—

Attachment

EN
26/10/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Generix Group SA

 PRESS RELEASE

Generix Group : Aïda Collette-Sène nommée Présidente du directoire de ...

Generix Group : Aïda Collette-Sène nommée Présidente du directoire de Generix Group                Communiqué de presse      Le 15 septembre 2022 Aïda Collette-Sène nommée Présidente du directoire de Generix Group Generix Group annonce que le Conseil de Surveillance a nommé Madame Aïda Collette-Sène aux fonctions de Présidente du Directoire, à compter du 1er septembre 2022. Directrice Générale de Generix Group depuis avril 2018, après un parcours de près de 20 ans au sein du groupe CGI, elle prend la succession de Monsieur Jean-Charles Deconninck qui dirigeait la société depui...

 PRESS RELEASE

Generix Group - Information relative au nombre total de droits de vote...

Generix Group - Information relative au nombre total de droits de vote et d’actions au 31 août 2022 COMMUNIQUE FINANCIER Lesquin, le 9 Septembre 2022 Generix Group - Information relative au nombre total de droits de vote et d’actions Prévue par l’article L. 233-8 II du Code de Commerce et l’article 223-16 du règlement général de l’Autorité des Marchés Financiers DateNombre d’actionsNombre de droits de vote théoriques des actions31/08/202222 703 86323 198 086 FR À propos de Generix Group  Generix Group est un expert de la Supply Chain Collaborative présent dans plus de 60 pays, grâce à...

 PRESS RELEASE

Résultat de l’Offre Publique d’Achat Simplifiée

Résultat de l’Offre Publique d’Achat Simplifiée Generix Group          Communiqué de presse          Le 25 août 2022 Résultat de l’Offre Publique d’Achat Simplifiée Generix Group et New Gen Holding annoncent que le 24 août 2022, l’Autorité des marchés financiers a publié les résultats de l’offre publique d’achat simplifiée clôturée le 19 août 2022 et visant la totalité des actions Generix Group non détenues par New Gen Holding. A l’issue de l’offre publique d’achat simplifiée, l’Initiateur New Gen Holding a acquis 6 589 041 actions dans le cadre de la procédure de semi-centralisation. ...

 PRESS RELEASE

Generix Group - Information relative au nombre total de droits de vote...

Generix Group - Information relative au nombre total de droits de vote et d’actions au 31 juillet 2022 COMMUNIQUE FINANCIER Lesquin, le 8 Août 2022 Generix Group - Information relative au nombre total de droits de vote et d’actions Prévue par l’article L. 233-8 II du Code de Commerce et l’article 223-16 du règlement général de l’Autorité des Marchés Financiers DateNombre d’actionsNombre de droits de vote théoriques des actions31/07/202222 703 86323 756 862 FR À propos de Generix Group  Generix Group est un expert de la Supply Chain Collaborative présent dans plus de 60 pays, grâce à s...

 PRESS RELEASE

Generix Group - Bilan semestriel du contrat de liquidité GENERIX contr...

Generix Group - Bilan semestriel du contrat de liquidité GENERIX contracté avec NATIXIS ODDO BHF COMMUNIQUE FINANCIER Lesquin, le 3 Aout 2022 Generix Group - Bilan semestriel du contrat de liquidité GENERIX contracté avec NATIXIS ODDO BHF Au titre du contrat de liquidité confié à NATIXIS ODDO BHF portant sur les actions de la société GENERIX, à la date du 30 Juin 2022, les moyens suivants figuraient au compte de liquidité : 27 099 titres GENERIX50 430.95€         Lors du dernier bilan semestriel, à la date du 31 Décembre 2021, les moyens suivants figuraient au compte de liquidité :   ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch